The characteristics of patients with lymphangioleiomyomatosis (LAM) are poorly defined, as they may present with or without pleural effusion (PE). We performed a systematic review across four electronic databases searching for studies reporting clinical findings, PE characteristics, and the most effective treatment of LAM. Case descriptions and retrospective studies were included, unrestricted by year of publication. The review consisted of 94 studies (199 patients) spanning a period of nearly 55 years. The median age was 38 years (range: 1 month to 69 years), and 79.7% were between 21 and 50 years old. All cases had dyspnea, 95% had a cough, and 87.5% had chest pain. PE was exudative chylothorax, usually unilateral (76%) and right-sided, predominantly lymphocytic, and with proportionately higher levels of proteins than lactate dehydrogenase. Sirolimus was effective in all cases, completely in 87%, and partially in 13%, although the number of patients receiving sirolimus was small. The present study confirmed that LAM and PE mainly occur in women of childbearing age (third to fifth decade of life). PE was usually unilateral and presented as a lymphocyte-predominant chylous exudate. The most effective treatment for PE seems to be sirolimus, although studies with larger series are needed to confirm this.

Keywords:
Chylothorax, Pleurectomy/decortication, Lymphangioleiomyomatosis, Pleural effusion, Pleural fluid , Sirolimus, Tuberous sclerosis complex
1.
Ryu JH, Moss J, Beck GJ, Lee JC, Brown KK, Chapman JT, et al: Characteristics of 230 patients at enrollment. The NHLBI Lymphangioleiomyomatosis Registry. Am J Respir Crit Care Med 2006;173:105-111.
2.
Costello LC, Hartman TE, Ryu JH: High frequency of pulmonary lymphangioleiomyomatosis in adult women with tuberous sclerosis complex. Mayo Clin Proc 2000;75:591-594.
3.
Roach ES, DiMario FJ, Kandt RS, Northrup H: Tuberous sclerosis consensus conference: recommendations for diagnostic evaluation. J Child Neurol 1999;14:402-407.
4.
Aubry MC, Myers JL, Ryu JH, Petri-Henske E, Jalal SM, Tazelaar HD: Pulmonary lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in a male patient with tuberous sclerosis complex. Am J Respir Crit Care Med 2000;162:749-752.
5.
Taveira-DaSilva AM, Moss J: Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis. Clin Epidemiol 2015;7:249-257.
6.
Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, et al: European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 2010;35:14-26.
7.
Johnson SR: Lymphangioleiomyomatosis. Eur Respir J 2006;27:1056-1065.
8.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
9.
Heppleston AG: The pathology of honeycomb lung. Thorax 1956;11:77-93.
10.
Laipply TC, Sherrick JC: Intrathoracic angiomyomatous hyperplasia associated with chronic chylothorax. Lab Invest 1958;7:387-400.
11.
Inglis K: The nature and origin of smooth-muscle-like neoplastic tissue in the lungs and corresponding lymph nodes in a case of so-called ‘honeycomb lungs'. Arch De Vecchi Anat Patol 1960;31:179-209.
12.
Correll N, Fischer C: Lymphangioma of the thoracic duct. JAMA 1962;182:1136.
13.
Justin Besancon L, Pequignot H, Galey JJ, Renault P, Even P: Acquired diffuse pulmonary lymphangiectasis with respiratory insufficiency and chylothorax. Sem Hop 1963;39:1179-1190.
14.
Pachter MR, Lattes R: Mesenchymal tumors of the mediastinum. III. Tumors of lymph vascular origin. Cancer 1963;16:108-117.
15.
Rienhoff WF 3rd, Shelley WM, Cornell WP: Lymphangiomatous malformation of thoracic duct associated with chylous pleural effusion. Ann Surg 1964;159:180-184.
16.
Cornog JL Jr, Enterline HT: Lymphangiomyoma, a benign lesion of chyliferous lymphatics synonymous with lymphangiopericytoma. Cancer 1966;19:1909-1930.
17.
Frack MD, Simon L, Dawson BH: The lymphangiomyomatosis syndrome. Cancer 1968;22:428-437.
18.
Collard M, Fievez M, Godart S, Toussaint JP: The contribution of lymphangiography in the study of diffuse lymphangiomyomatosis. Report of a case with anatomic observations. Am J Roentgenol Radium Ther Nucl Med 1968;102:466-470.
19.
Pamukcoglu T: Lymphangiomyoma of the thoracic duct with honeycomb lungs. Am Rev Respir Dis 1968;97:295-301.
20.
Bush JK, McLean RL, Sieker HO: Diffuse lung disease due to lymphangiomyoma. Am J Med 1969;46:645-654.
21.
Broughton RB: Pulmonary tuberous sclerosis presenting with pleural effusion. Br Med J 1970;1:477-478.
22.
Wolff M: Lymphangiomyoma: clinicopathologic study and ultrastructural confirmation of its histogenesis. Cancer 1973;31:988-1007.
23.
Lieberman J, Agliozzo CM: Intrapleural nitrogen mustard for treating chylous effusion of pulmonary lymphangioleiomyomatosis. Cancer 1974;33:1505-1511.
24.
Silverstein EF, Ellis K, Wolff M, Jaretzki A 3rd: Pulmonary lymphangiomyomatosis. Am J Roentgenol Radium Ther Nucl Med 1974;120:832-850.
25.
Corrin B, Liebow AA, Friedman PJ: Pulmonary lymphangiomyomatosis. A review. Am J Pathol 1975;79:348-382.
26.
Shuman RL, Engelman R, Kittle CF: Pulmonary lymphangiomyomatosis. Ann Thorac Surg 1979;27:70-75.
27.
Berger JL, Shaff MI: Pulmonary lymphangioleiomyomatosis. J Comput Assist Tomogr 1981;5:565-567.
28.
Svendsen TL, Viskum K, Hansborg N, Thorpe SM, Nielsen NC: Pulmonary lymphangioleiomyomatosis: a case of progesterone receptor positive lymphangioleiomyomatosis treated with medroxyprogesterone, oophorectomy and tamoxifen. Br J Dis Chest 1984;78:264-271.
29.
Sobonya RE, Quan SF, Fleishman JS: Pulmonary lymphangioleiomyomatosis: quantitative analysis of lesions producing airflow limitation. Hum Pathol 1985;16:1122-1128.
30.
Adamson D, Heinrichs WL, Raybin DM, Raffin TA: Successful treatment of pulmonary lymphangiomyomatosis with oophorectomy and progesterone. Am Rev Respir Dis 1985;132:916-921.
31.
Merchant RN, Pearson MG, Rankin RN, Morgan WK: Computerized tomography in the diagnosis of lymphangioleiomyomatosis. Am Rev Respir Dis 1985;131:295-297.
32.
Bertolani M, Romagnoli R, Barbolini G: Diagnostic approach to pulmonary lymphangioleiomyomatosis. Case report. Eur J Radiol 1987;7:60-62.
33.
Murray DP, O'Sullivan DJ: Pulmonary tuberous sclerosis responds to progesterone treatment. Ir J Med Sci 1988;157:196-197.
34.
Rodríguez Vela L, Ariño I, Liédana JM, Horndler C, Roncalés A, Rioja C, Rioja LA: Bilateral angiomyolipomas of the kidney in Bourneville's tuberous sclerosis. Arch Esp Urol 1989;42:423-431.
35.
Swank DW, Hepper NG, Folkert KE, Colby TV: Intrathoracic lymphangiomatosis mimicking lymphangioleiomyomatosis in a young woman. Mayo Clin Proc 1989;64:1264-1268.
36.
Sherrier RH, Chiles C, Roggli V: Pulmonary lymphangioleiomyomatosis: CT findings. AJR Am J Roentgenol 1989;153:937-940.
37.
Foresti V, Casati O, Zubani R, Villa A: Chylous pleural effusion in tuberous sclerosis. Respiration 1990;57:398-401.
38.
Taylor JR, Ryu J, Colby TV, Raffin TA: Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 1990;323:1254-1260.
39.
Hede J, Jurik AG: Lymphangioleiomyomatosis. Diagnostic imaging approach to a rare disease in women. Röfo 1991;155:582-584.
40.
Spencer JA, Smith MJ, Golding SJ: Lymphangioleiomyomatosis with unusual calcific retroperitoneal lymphangiomyoma: CT findings. Eur J Radiol 1992;14:192-194.
41.
Woodring JH, Howard RS 2nd, Johnson MV: Massive low-attenuation mediastinal, retroperitoneal, and pelvic lymphadenopathy on CT from lymphangioleiomyomatosis. Case report. Clin Imaging 1994;18:7-11.
42.
Ernst JC, Sohaey R, Cary JM: Pelvic lymphangioleiomyomatosis. Atypical precursor to pulmonary disease. Chest 1994;106:1267-1269.
43.
Kitaichi M, Nishimura K, Itoh H, Izumi T: Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995;151:527-533.
44.
Khan SU, Mehta AC: Chyloptyses found in a patient with lymphangioleiomyomatosis. Chest 1995;108:1775.
45.
Druelle S, Aubry P, Levi-Valensi P: Pulmonary lymphangiomyomatosis: a 3-year follow-up of medroxyprogesterone acetate therapy. Apropos of a case. Rev Pneumol Clin 1995;51:284-287.
46.
Zanella A, Toppan P, Nitti D, Lise M: Pulmonary lymphangioleiomyomatosis: a case report in postmenopausal woman treated with pleurodesis and progesterone (medroxyprogesterone acetate). Tumori 1996;82:96-98.
47.
Dweik RA, Arroliga AC: A 36-year-old woman with progressive shortness of breath and chylous pleural effusion. Cleve Clin J Med 1996;63:129-131.
48.
Longacre TA, Hendrickson MR, Kapp DS, Teng NN: Lymphangioleiomyomatosis of the uterus simulating high-stage endometrial stromal sarcoma. Gynecol Oncol 1996;63:404-410.
49.
Jounieaux V, Druelle S, Mayeux I, Grimault E, Charet JC: Progesterone treatment in chylothorax associated with pulmonary tuberous sclerosis. Eur Respir J 1996;9:2423-2425.
50.
Itami M, Teshima S, Asakuma Y, Chino H, Aoyama K, Fukushima N: Pulmonary lymphangiomyomatosis diagnosed by effusion cytology. A case report. Acta Cytol 1997;41:522-528.
51.
Matthews LM: Fine needle aspiration diagnosis of lymphangiomyomatosis. A case report. Acta Cytol 1999;43:1155-1158.
52.
Collins J, Müller NL, Kazerooni EA, Mc Adams HP, Leung AN, Love RB: Lung transplantation for lymphangioleiomyomatosis: role of imaging in the assessment of complications related to the underlying disease. Radiology 1999;210:325-332.
53.
Cope C, Salem R, Kaiser LR: Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J Vasc Interv Radiol 1999;10:1248-1254.
54.
Kirchner J, Stein A, Viel K, Dietrich CF, Thalhammer A, Schneider M, et al: Pulmonary lymphangioleiomyomatosis: high-resolution CT findings. Eur Radiol 1999;9:49-54.
55.
Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, et al: Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999;115:1041-1052.
56.
Kun KY, Tang R, Tai CM, Ng TK: Tuberous sclerosis in a Chinese baby presented with a pleural effusion and cardiac tumour during prenatal period. J Obstet Gynaecol 1999;19:429-430.
57.
Johnson SR, Tattersfield AE: Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000;55:1052-1057.
58.
Yamauchi M, Nakahara H, Uyama K, Tsujimoto A, Tamai M, Aozasa K: Cytologic finding of chyloascites in lymphangioleiomyomatosis. A case report. Acta Cytol 2000;44:1081-1084.
59.
Matsui K, Tatsuguchi A, Valencia J, Yu Zx, Bechtle J, Beasley MB, et al: Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. Hum Pathol 2000;31:1242-1248.
60.
López-García F, Romero-Sanz V, Carratalá-Torregrosa JA, Andrada-Becerra E, Shum-Funk C, Martín-Hidalgo A: Pulmonary lymphangioleiomyomatosis. Description and course of 2 cases. An Med Interna 2000;17:599-602.
61.
Morimoto N, Hirasaki S, Kamei T, Horiike A, Miyatake H, Ogita Y, et al: Pulmonary lymphangiomyomatosis (LAM) developing chylothorax. Intern Med 2000;39:738-741.
62.
Kaptanoglu M, Hatipoglu A, Kutluay L, Gunay L, Dogan K: Bilateral chylothorax caused by pleuropulmonary lymphangiomyomatosis: a challenging problem in thoracic surgery. Scand Cardiovasc J 2001;35:151-154.
63.
Ryu JH, Doerr CH, Fisher SD, Olson EJ, Sahn SA: Chylothorax in lymphangioleiomyomatosis. Chest 2003;123:623-627.
64.
Cowen EW, Rabel A, Nava V, Turner M, Moss J: Eruptive linear papules on the abdomen of a woman with ascites. J Am Acad Dermatol 2004;51:75-78.
65.
Bearz A, Rupolo M, Canzonieri V, Balestreri L, La Mura N, Berretta M, et al: Lymphangioleiomyomatosis: a case report and review of the literature. Tumori 2004;90:528-531.
66.
Bhat MA, Bhat GM: Pulmonary lymphangioleiomyomatosis: a rare presentation. Indian J Chest Dis Allied Sci 2004;46:209-211.
67.
Abbott GF, Rosado-de-Christenson ML, Frazier AA, Franks TJ, Pugatch RD, Galvin JR: From the archives of the AFIP: lymphangioleiomyomatosis: radiologic-pathologic correlation. Radiographics 2005;25:803-828.
68.
Kumasaka T, Seyama K, Mitani K, Souma S, Kashiwagi S, Hebisawa A, et al: Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis. Am J Surg Pathol 2005;29:1356-1366.
69.
Kishi K, Homma S, Miyamoto A, Kurosaki A, Motoi N, Kohno T, et al: Rounded atelectasis associated with pulmonary lymphangioleiomyomatosis. Intern Med 2005;44:625-627.
70.
Christodoulou M, Ris HB, Pezzetta E: Video-assisted right supradiaphragmatic thoracic duct ligation for non-traumatic recurrent chylothorax. Eur J Cardiothorac Surg 2006;29:810-814.
71.
Tynski Z, Eisenberg R: Cytologic findings of lymphangioleiomyomatosis in pleural effusion: a case report. Acta Cytol 2007;51:578-580.
72.
Hirama M, Atsuta R, Mitani K, Kumasaka T, Gunji Y, Sasaki S, et al: Lymphangioleiomyomatosis diagnosed by immunocytochemical and genetic analysis of lymphangioleiomyomatosis cell clusters found in chylous pleural effusion. Intern Med 2007;46:1593-1596.
73.
Kaya S, Dursunoglu N: Non-malignant thoracic pathologies of the women of reproductive age. Can we suggest to collect them under the same heading? Maturitas 2007;58:316-318.
74.
Shawki HB, Muhammed SM, Reda AN, Abdulla TS, Ardalan DM: Pulmonary lymphangioleiomyomatosis. Saudi Med J 2007;28:131-134.
75.
De Lima AS, Martynychen MG, Florêncio RT, Rabello LM, de Barros JA, Escuissato DL: Pulmonary lymphangiomatosis: a report of two cases. J Bras Pneumol 2007;33:229-233.
76.
Fremont RD, Milstone AP, Light RW, Ninan M: Chylothoraces after lung transplantation for lymphangioleiomyomatosis: review of the literature and utilization of a pleurovenous shunt. J Heart Lung Transplant 2007;26:953-955.
77.
Warth A, Herpel E, Schmähl A, Hoffmann H, Herth FJ, Schirmacher P, et al: Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis. Eur Respir J 2008;31:678-680.
78.
Ohara T, Oto T, Miyoshi K, Tao H, Yamane M, Toyooka S, et al: Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis. Ann Thorac Surg 2008;86:e7-e8.
79.
Sugimoto R, Nakao A, Yamane M, Toyooka S, Okazaki M, Aoe M, et al: Sirolimus amelioration of clinical symptoms of recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation. J Heart Lung Transplant 2008;27:921-924.
80.
Billings ME, Mulligan M, Raghu G: Acute constrictive pericarditis after lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant 2009;28:110-113.
81.
Malinowska-Kolodziej I, Finlay G, Campbell G, Garcia-Moliner ML, Weinstein B, Doughty CA, et al: Lymphangioleiomyomatosis: cause of a malignant chylous pleural effusion. J Clin Oncol 2010;28:4-6.
82.
Takagi Y, Sato T, Morio Y, Kumasaka T, Mitani K, Miyamoto H, et al: A pleuro-peritoneal communication through the diaphragm affected with lymphangioleiomyomatosis. Intern Med 2010;49:439-445.
83.
Befort P, Corne P, Bourdin A, Bommart S, Jonquet O: Pleural effusion, cystic pulmonary disease and renal mass. Rev Mal Respir 2010;27:497-499.
84.
Bisceglia M, D'Alessandro V, Simeone A, Ben-Dor D, Pasquinelli G: Selected case from the Arkadi M. Rywlin International Pathology Slide Seminar: sporadic lymphangioleiomyomatosis. Adv Anat Pathol 2010;17:445-452.
85.
Dursunoglu N, Ors S, Gunay S, Bir F, Başer S, Ozkurt S, et al: A young lady with severe dyspnea in postpartum period after long term infertility treatment. Turk Toraks Dergisi 2011;12:127-129.
86.
Taveira-DaSilva AM, Hathaway O, Stylianou M, Moss J: Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. Ann Intern Med 2011;154:797-805.
87.
Min HK, Jung JI, Song JS, Park CK, Kim YK, Kang JY: A 29-year-old woman with an intractable postoperative pleural effusion and pulmonary parenchymal opacification. Chest 2012;142:791-796.
88.
Palmeiro R, Arosa V, Cuerda C, Bretón I, Camblor M, Rodríguez MC, et al: Persistent chylothorax in patient with lymphangioleiomyomatosis. Nutr Hosp 2012;27:940-942.
89.
Moua T, Olson EJ, Jean HCS, Ryu JH: Resolution of chylous pulmonary congestion and respiratory failure in lymphangioleiomyomatosis with sirolimus therapy. Am J Respir Crit Care Med 2012;186:389-390.
90.
Chachaj A, Drozdz K, Chabowski M, Dziegiel P, Grzegorek I, Wojnar A, et al: Chyloperitoneum, chylothorax and lower extremity lymphedema in woman with sporadic lymphangioleiomyomatosis successfully treated with sirolimus: a case report. Lymphology 2012;45:53-57.
91.
Rozenberg D, Thenganatt J: Dramatic response to sirolimus in lymphangioleiomyomatosis. Can Respir J 2013;20:413-414.
92.
Ansótegui-Barrera E, Mancheño-Franch N, Peñalver-Cuesta JC, Vera-Sempere F, Padilla-Alarcón J: Lung transplantation in sporadic lymphangioleiomyomatosis: study of 7 cases. Med Clin (Barc) 2013;141:349-352.
93.
Sharp C, Meller M, Moody A, Hands G: A hormonal effusion? Thorax 2013;68:697-698.
94.
Barrera P, Simons SO, Luijk B, Wessels MJ, Heijdra YF: Efficacy of sirolimus therapy for chylous effusions in lymphangioleiomyomatosis. Ann Am Thorac Soc 2013;10:408-409.
95.
Ando K, Kurihara M, Kataoka H, Ueyama M, Togo S, Sato T, et al: Efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis. Respir Investig 2013;51:175-183.
96.
Csiszkó A, Herr G, Sz Kiss S, Hallay J, Gyöngyösi Z, Szentkereszty Z: VATS therapy of chylothorax caused by leiomyomatosis complicated with tuberous sclerosis complex. J Minim Access Surg 2013;9:84-86.
97.
Fan D, Ding L, Liu H, Wang J, Ran W, Li Y, et al: Effusion cytology: an effective method for the diagnosis of pulmonary lymphangioleiomyomatosis. J Thorac Dis 2014;6:54-57.
98.
Khoja AM, Duggal D, Keni A, Patel CS, Chavan R: Palliative management of lymphangioleiomyomatosis: using video-assisted thoracoscopic surgery. J Bronchol Interv Pulmonol 2014;21:54-57.
99.
Liu M, Wu B, Cui Y, Chang D, Zhang S, Gong M: Surgical treatment of chylothorax caused by lymphangioleiomyomatosis. J Thorac Dis 2014;6:11-14.
100.
Cai X, Pacheco-Rodriguez G, Haughey M, Samsel L, Xu S, Wu HP, et al: Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis. Chest 2014;145:108-112.
101.
Hussein M, Aljehani YM, Nizami I, Saleh W: Successful management of bilateral refractory chylothorax after double lung transplantation for lymphangioleiomyomatosis. Ann Thorac Med 2014;9:124-126.
102.
Kinoshita Y, Sakamoto A, Hidaka K: Recovery of chylous pulmonary congestion in tuberous sclerosis complex-associated lymphangioleiomyomatosis. BMJ Case Rep 2014, DOI: 10.1136/bcr-2014-205701.
103.
McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, et al: Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 2011;364:1595-1606.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.